ATE303370T1 - Il-8 rezeptor antagonisten - Google Patents
Il-8 rezeptor antagonistenInfo
- Publication number
- ATE303370T1 ATE303370T1 AT98944775T AT98944775T ATE303370T1 AT E303370 T1 ATE303370 T1 AT E303370T1 AT 98944775 T AT98944775 T AT 98944775T AT 98944775 T AT98944775 T AT 98944775T AT E303370 T1 ATE303370 T1 AT E303370T1
- Authority
- AT
- Austria
- Prior art keywords
- receptor antagonists
- antagonists
- receptor
- Prior art date
Links
- 108090001007 Interleukin-8 Proteins 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Transplantation (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5799797P | 1997-09-05 | 1997-09-05 | |
| PCT/US1998/018563 WO1999011253A1 (en) | 1997-09-05 | 1998-09-04 | Il-8 receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE303370T1 true ATE303370T1 (de) | 2005-09-15 |
Family
ID=22014018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98944775T ATE303370T1 (de) | 1997-09-05 | 1998-09-04 | Il-8 rezeptor antagonisten |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6316478B1 (de) |
| EP (1) | EP1003497B1 (de) |
| JP (1) | JP2001514217A (de) |
| KR (1) | KR20010023673A (de) |
| CN (1) | CN1278721A (de) |
| AR (1) | AR015426A1 (de) |
| AT (1) | ATE303370T1 (de) |
| AU (1) | AU731182B2 (de) |
| BR (1) | BR9811751A (de) |
| CA (1) | CA2302364A1 (de) |
| CO (1) | CO4970746A1 (de) |
| DE (1) | DE69831413T2 (de) |
| ES (1) | ES2248916T3 (de) |
| HU (1) | HUP0003581A3 (de) |
| IL (1) | IL134854A0 (de) |
| NO (1) | NO315467B1 (de) |
| NZ (1) | NZ503125A (de) |
| PL (1) | PL339133A1 (de) |
| TR (1) | TR200000610T2 (de) |
| WO (1) | WO1999011253A1 (de) |
| ZA (1) | ZA988101B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR008331A1 (es) * | 1997-01-23 | 1999-12-29 | Smithkline Beecham Corp | Compuestos antagonistas de un receptor de il-8, uso de los mismos para la fabricacion de medicamentos, procedimiento para su obtencion, composicionesfarmaceuticas que los contienen |
| US6664259B2 (en) * | 2000-03-16 | 2003-12-16 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
| DE10038709A1 (de) * | 2000-08-09 | 2002-02-28 | Aventis Pharma Gmbh | Substituierte und unsubstituierte Benzooxathiazole sowie daraus abgeleitete Verbindungen |
| MY143477A (en) * | 2002-10-29 | 2011-05-31 | Smithkline Beecham Corp | Il-8 receptor antagonists |
| CA2565519A1 (en) | 2004-05-12 | 2005-12-01 | Schering Corporation | Cxcr1 and cxcr2 chemokine antagonists |
| JP2008517054A (ja) * | 2004-10-20 | 2008-05-22 | スミスクライン・ビーチャム・コーポレイション | Ｉｌ−８受容体アンタゴニスト |
| UA98456C2 (en) * | 2006-04-21 | 2012-05-25 | Смитклайн Бичам Корпорейшн | Il-8 receptor antagonists |
| WO2007124423A2 (en) * | 2006-04-21 | 2007-11-01 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
| CL2007001829A1 (es) * | 2006-06-23 | 2008-01-25 | Smithkline Beecham Corp | P-toluensulfonato de n-[4-cloro-2-hidroxi-3-(piperazina-1-sulfonil)fenil]-n-(2-cloro-3-fluorofenil)urea;procedimiento de preparacion;composicion farmaceutica;combinacion farmaceutica;y uso en el tratamiento de una enfermedad mediada por la quiimioquina il-8, tales como asma y epoc. |
| KR101182114B1 (ko) * | 2010-03-05 | 2012-09-12 | 한림제약(주) | 유효성분으로서 레바미피드를 함유하는 골관절염 예방 또는 치료용 약학 조성물 |
| MX2018016416A (es) * | 2016-07-04 | 2019-05-09 | Bayer Cropscience Ag | Benzosultamas y sus analogos y sus usos como fungicidas. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1327482A (en) * | 1970-06-30 | 1973-08-22 | Leo Pharm Prod Ltd | 1,2-benzisothiazole-1,1-dioxide derivatives |
| US5593993A (en) | 1991-08-02 | 1997-01-14 | Medivir Ab | Method for inhibition of HIV related viruses |
| AR008331A1 (es) * | 1997-01-23 | 1999-12-29 | Smithkline Beecham Corp | Compuestos antagonistas de un receptor de il-8, uso de los mismos para la fabricacion de medicamentos, procedimiento para su obtencion, composicionesfarmaceuticas que los contienen |
-
1998
- 1998-09-01 AR ARP980104363A patent/AR015426A1/es unknown
- 1998-09-04 AU AU92233/98A patent/AU731182B2/en not_active Ceased
- 1998-09-04 US US09/486,986 patent/US6316478B1/en not_active Expired - Fee Related
- 1998-09-04 TR TR2000/00610T patent/TR200000610T2/xx unknown
- 1998-09-04 WO PCT/US1998/018563 patent/WO1999011253A1/en not_active Ceased
- 1998-09-04 DE DE69831413T patent/DE69831413T2/de not_active Expired - Fee Related
- 1998-09-04 HU HU0003581A patent/HUP0003581A3/hu unknown
- 1998-09-04 EP EP98944775A patent/EP1003497B1/de not_active Expired - Lifetime
- 1998-09-04 BR BR9811751-3A patent/BR9811751A/pt not_active Application Discontinuation
- 1998-09-04 AT AT98944775T patent/ATE303370T1/de not_active IP Right Cessation
- 1998-09-04 ZA ZA988101A patent/ZA988101B/xx unknown
- 1998-09-04 IL IL13485498A patent/IL134854A0/xx unknown
- 1998-09-04 CA CA002302364A patent/CA2302364A1/en not_active Abandoned
- 1998-09-04 CO CO98050794A patent/CO4970746A1/es unknown
- 1998-09-04 CN CN98810929A patent/CN1278721A/zh active Pending
- 1998-09-04 KR KR1020007002326A patent/KR20010023673A/ko not_active Withdrawn
- 1998-09-04 JP JP2000508356A patent/JP2001514217A/ja active Pending
- 1998-09-04 PL PL98339133A patent/PL339133A1/xx unknown
- 1998-09-04 ES ES98944775T patent/ES2248916T3/es not_active Expired - Lifetime
-
2000
- 2000-02-29 NZ NZ503125A patent/NZ503125A/en unknown
- 2000-03-03 NO NO20001099A patent/NO315467B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU731182B2 (en) | 2001-03-22 |
| NZ503125A (en) | 2002-05-31 |
| IL134854A0 (en) | 2001-05-20 |
| DE69831413T2 (de) | 2006-06-14 |
| PL339133A1 (en) | 2000-12-04 |
| EP1003497A4 (de) | 2002-11-13 |
| EP1003497A1 (de) | 2000-05-31 |
| TR200000610T2 (tr) | 2000-09-21 |
| DE69831413D1 (de) | 2005-10-06 |
| ES2248916T3 (es) | 2006-03-16 |
| CO4970746A1 (es) | 2000-11-07 |
| KR20010023673A (ko) | 2001-03-26 |
| EP1003497B1 (de) | 2005-08-31 |
| ZA988101B (en) | 1999-03-05 |
| HK1028730A1 (en) | 2001-03-02 |
| WO1999011253A1 (en) | 1999-03-11 |
| NO315467B1 (no) | 2003-09-08 |
| NO20001099D0 (no) | 2000-03-03 |
| AU9223398A (en) | 1999-03-22 |
| NO20001099L (no) | 2000-03-03 |
| HUP0003581A2 (hu) | 2001-09-28 |
| JP2001514217A (ja) | 2001-09-11 |
| US6316478B1 (en) | 2001-11-13 |
| CN1278721A (zh) | 2001-01-03 |
| CA2302364A1 (en) | 1999-03-11 |
| AR015426A1 (es) | 2001-05-02 |
| BR9811751A (pt) | 2001-11-13 |
| HUP0003581A3 (en) | 2002-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20001100D0 (no) | IL-8 reseptorantagonister | |
| NO986110D0 (no) | IL-8 reseptor-antagonister | |
| NO986109D0 (no) | IL-8 reseptor-antagonister | |
| NO983737L (no) | IL-8 reseptor antagonister | |
| DE69812096D1 (de) | Neuropeptid y rezeptorantagonisten | |
| NO990668L (no) | IL-8 reseptor antagonister | |
| ATE315035T1 (de) | Ccr-3-rezeptor-antagonisten | |
| DE69734833D1 (de) | Vitronektin rezeptor antagonisten | |
| EP0991406A4 (de) | Il-8 rezeptorantagonisten | |
| ATE280157T1 (de) | 4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii | |
| NO993350D0 (no) | Vitronectin-reseptor-antagonister | |
| ID24726A (id) | Antagonis-antagonis reseptor trombin | |
| ID24162A (id) | Antagonis-antagonis reseptor vitronektin | |
| NO20016053D0 (no) | IL-8 reseptor-antagonister | |
| ATE381330T1 (de) | Il-8 rezeptor-antagonisten | |
| NO20016052L (no) | IL-8-reseptor-antagonister | |
| DE69831413T2 (de) | Il-8 rezeptor antagonisten | |
| DE69824837D1 (de) | Il-8-rezeptor-antagonisten | |
| DK1180028T3 (da) | IL-8-receptorantagonister | |
| NO20015774L (no) | IL-8 reseptorantagonister | |
| NO20010353D0 (no) | IL-8 reseptor-antagonist | |
| NO20016102L (no) | IL-8 reseptorantagonister | |
| NO20016065L (no) | IL-8-reseptor-antagonister |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |